For authors

Submit your manuscript

Biomolecules and Biomedicine is an open-access journal publishing pre-clinical, translational and clinical research. Everything you need to prepare and submit is on this page.

  • 2 daysEditorial screening
  • 24 daysMedian peer review time
  • 1 dayMedian acceptance to online publication
  • CC BY 4.0Open access, authors keep copyright

Before you submit

Use this checklist to confirm your submission is complete. Each item links to the details on this page.

Author information and ORCID

Provide the full names, email addresses and ORCID iDs of all co-authors. The emails of all authors are entered during online submission, and every author receives an email to link their ORCID iD with the submission. Why the ORCID iD matters.

Cover letter

Your cover letter should include:

  • why the manuscript should be published in Biomolecules and Biomedicine;
  • any issues relating to journal policies;
  • a declaration of potential competing interests;
  • suggested or excluded peer reviewers, if you wish. Give institutional email addresses where possible, or an ORCID or Scopus ID that lets the Editor verify the reviewer's identity. Intentionally falsified reviewer information leads to rejection and may affect future submissions;
  • the submission numbers or titles of manuscripts you have reviewed for the journal, if you are claiming benefits for reviewers;
  • whether the article has been shared as a preprint. Preprints are welcome.

How to submit

  1. Register or log in on the journal website.
  2. Follow the multistep process to enter the submission details and upload your files.

Article types

Select the category that best fits your work. The Editors may reclassify a submission. The journal sets no word or reference limits.

Type What we look for Submission
Research article Original clinical, translational, experimental, methodological or population-based findings Open
Review Critical, balanced synthesis of a topic, with future directions Open
Systematic review / Meta-analysis Systematic, reproducible synthesis following PRISMA Open
Short communication Brief original findings with one clear message Open
Case report with a literature review Novel or rare cases set in the context of the literature Open
Video article Techniques and methods best shown on video Open
Letter to the editor Comments on recently published articles, short observations Open
Special article Guidelines, statements, opinion articles Usually invited
Commentary Expert perspective on an article or emerging topic Usually invited

Research article

  • Scope: clinical, translational, experimental, methodological or population-based studies.
  • Structure: IMRaD (Introduction, Methods, Results, Discussion), with clear objectives, transparent methods and robust statistics.
  • Requirements: ethics approval and informed consent statements where applicable; a clear description of study design, sample size and statistical analysis; a data availability statement where relevant.

Review

  • Scope: narrative or focused reviews on clinically or biologically relevant subjects, covering recent advances, controversies and knowledge gaps.
  • Content: clear objectives, a structured synthesis of the literature, critical appraisal and a section on future directions.
  • Data: no new, previously unpublished primary data, except illustrative examples clearly labeled as such.

Systematic review / Meta-analysis

  • Scope: quantitative or qualitative syntheses that address a clearly formulated question with systematic, reproducible methods.
  • Standards: PRISMA is strongly encouraged (PRISMA-P for protocols). Registration of the protocol in a public registry such as PROSPERO is recommended and should be stated.
  • Content: full description of the search strategy, inclusion and exclusion criteria, study selection, risk-of-bias assessment, data extraction and synthesis methods.
  • Meta-analysis: effect sizes and heterogeneity measures, with appropriate sensitivity analyses.

Short communication

  • Scope: novel preliminary findings, concise clinical or methodological observations, or secondary analyses of high interest.
  • Content: focused text with a single clear message, a limited number of tables and figures, and a succinct discussion.
  • Data: methods and statistics described in enough detail to allow interpretation and, where possible, replication.

Case report with a literature review

  • Scope: single cases or small series that illustrate novel or rare presentations, diagnostic challenges, therapeutic approaches or mechanisms, set within a focused literature review.
  • Structure: introduction, detailed case description, discussion that integrates a concise, critical review of the literature, and clear learning points.
  • Requirements: written informed consent from the patient or legal guardian, and enough clinical, imaging or pathological detail to support the conclusions.

Video article

  • Scope: procedural techniques, laboratory methods, imaging protocols or other content that benefits from dynamic demonstration.
  • Content: a short text covering background, indications, step-by-step methods and key pitfalls, plus a video with clear narration or subtitles in English.
  • Patient data: all patient-identifiable information removed or fully anonymized; explicit consent is required when patients are visible or identifiable.

Letter to the editor

  • Scope: comments on articles recently published in the journal, or short observations, hypotheses or clarifications within its scope.
  • Content: objective, respectful tone with a clear main point, a short text and few or no figures and tables. Authors of the discussed article may be invited to respond.

Special article (guideline, statement, opinion)

  • Scope: clinical or methodological guidelines, position or consensus statements, and opinion pieces. Usually invited, but high-quality unsolicited manuscripts may be considered.
  • Guidelines and statements: describe the methodology for evidence review and consensus, and present recommendations clearly.
  • Opinion articles: balanced, evidence-informed, and clearly distinguished as opinion rather than original data.

Commentary

  • Scope: usually invited; expert perspective on articles recently published in the journal or on emerging concepts, policy issues or methods.
  • Content: a concise, scholarly discussion that places the topic in a broader context.
  • Conflict of interest: any potential conflicts, including involvement in related studies or guidelines, must be declared.

Manuscript preparation

Recently published articles in the current issue show the structure the journal expects.

Structure and formatting

Download and use the BiomolBiomed manuscript template to avoid formatting errors. The main manuscript file contains, in this order:

  1. Title page
  2. Abstract and keywords
  3. Text
  4. Acknowledgements (if applicable)
  5. Declaration of interest
  6. References
  7. Tables
  8. Figures with figure legends
  • Title page: a title of no more than 15 words; full first and last names of the authors and their institutions; the corresponding author's address and email.
  • Abstract: about 250 words, unstructured (no subheadings), stating the objective, basic methods, main results with specific data and their statistical significance where possible, and the principal conclusions. Letters to the editor and Commentaries do not need an abstract.
  • Keywords: 3 to 10 keywords or short phrases, where possible from the Medical Subject Headings list.
  • Text: research articles use the sections Introduction, Materials and Methods (including ethical and statistical information), Results, Discussion and Conclusion. Reviews may use a different format.
  • File size: the text file cannot exceed 5 MB.

Scientific writing and English language

Before submitting, check your manuscript against the appropriate reporting guideline. GoodReports helps you find it, and the guidelines themselves are at the EQUATOR Network. Penelope.ai can help with an initial completeness check.

Manuscripts must conform to standard scientific English in style, grammar and clarity. Authors who feel their manuscript would benefit from language support are encouraged to seek it at their institution, from colleagues, or from a professional editing service before submission. Well-written manuscripts have a much better chance of acceptance.

Tables

Place tables at the end of the manuscript and number them in the order they appear in the text, e.g., (Table 3). Refer to every table in the text. Give each table a brief, self-explanatory title, with essential explanations below the table. Identify statistical measures of variation such as standard deviation and standard error of the mean.

Figures

  • Refer to figures in order of appearance, in Arabic numerals in parentheses, e.g., (Figure 2).
  • Resolution: 600 dpi for line art, 300 dpi for halftones and color.
  • Width: about 80 mm (one column) or, where needed, about 160 mm.
  • Each figure file cannot exceed 5 MB.
  • Photographs of people must have identities obscured or be accompanied by written consent.
  • Previously published figures need an acknowledged source and written permission from the copyright holder for print and electronic formats, except for public-domain material.
  • Figures may be reduced, cropped or deleted at the discretion of the Editor.

See the figure guidelines for details.

Blot and gel reporting

Authors must be able to provide the original, uncropped and unadjusted blot and gel images during peer review or before acceptance. The Editorial Office will request them by email or, for large files, through a file transfer service. The journal's policy is built on the PLOS ONE Blot and Gel Reporting Requirements.

Clinical trial registration

Randomized controlled trials (RCTs) must be registered in a publicly accessible registry before submission. Provide the registration number from a recognized registry, such as the WHO International Clinical Trials Registry Platform (ICTRP) or ClinicalTrials.gov, in line with ICMJE guidelines. The registry must include the minimum 24-item trial registration data set. Manuscripts without trial registration may be rejected without review.

Units and abbreviations

Report length, height, weight and volume in metric units, and hematologic and clinical chemistry measurements in the International System of Units (SI). Define abbreviations at first use, use only standard ones, and avoid them in the title and abstract.

References

Number references consecutively in the order they first appear in the text, using Arabic numerals in square brackets, e.g., [17]. List all authors when there are six or fewer; with seven or more, list the first six followed by et al. Use Vancouver style with full titles and journal names abbreviated as in MEDLINE. For other source types, see Citing Medicine, 2nd edition.

Journal article
Wang Y, Goh LL, Chin KY. D-galactose-induced osteoporosis in rodents—Model development, skeletal characteristics, and optimal dosing regimens: A scoping review. Biomol Biomed. 2026;26(11):1913–1933. https://doi.org/10.17305/bb.2026.13914

More than six authors
Karcı E, Ozden F, Kuzucular E, Acikgoz O, Ölmez ÖF, Yildiz O, et al. Claudin 18.2, IDH1, and neutrophil-to-lymphocyte ratio as prognostic biomarkers in unresectable pancreatic ductal adenocarcinoma receiving first-line chemotherapy. Biomol Biomed. 2026;26(11):2117–2124. https://doi.org/10.17305/bb.2026.14093

Book
Heger JW, Niemann JT, Criley JM. Cardiology, 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2003.

Chapter in a book
Braunwald E, Perloff JK. Physical examination of the heart and circulation. In: Braunwald E, Zipes DP, Libby P (eds). Heart disease: a textbook of cardiovascular medicine, 6th ed. Philadelphia: WB Saunders; 2001, pp. 45–81.

Personal communications and unpublished work appear in parentheses in the text, not in the reference list. Work accepted but not yet published is listed with "in press" after the journal name. Authors must verify references against the original documents.

After submission

  1. Editorial screening Scope and quality check, usually within 1–3 days
  2. Peer review Double-blind, 2 to 5 external reviewers
  3. Decision Accept, minor revision, major revision or reject
  4. Revision Two weeks for minor, three months for major changes
  5. Publication DOI and Advance Online shortly after acceptance

Peer review

Each manuscript is assigned to the Editor best suited to handle it. Manuscripts that are outside the journal's scope or of insufficient quality are rejected without external review, usually within 1–3 days.

Other manuscripts are sent to at least 2 and at most 5 external reviewers. Review is double-blind: reviewers do not know who the authors are, and authors do not know who the reviewers are. The Editor handling a manuscript cannot act as its external reviewer.

Reviewers recommend acceptance, minor revision, major revision or rejection. Based on their reports, the Editor decides to publish unaltered, consider after minor changes, consider after major changes, or reject. A manuscript is rejected if the Editor or two of the reviewers recommend rejection. The median peer review time is 24 days.

Accepted manuscripts are assigned a DOI and published in the Advance Online section shortly after acceptance.

Revision and response to reviewers

  • Minor changes: submit the revised manuscript within two weeks.
  • Major changes: submit the revised manuscript within three months. Later submissions are treated as new and go through the full review process again.
  • If you cannot meet a deadline, notify the Editorial Office.

Provide a detailed response letter: copy each reviewer comment and answer it specifically, state which changes were made, and highlight them in the revised manuscript. Avoid general statements such as "comment accepted". Write the letter so that it can be forwarded to the reviewers without editing.

Withdrawing a manuscript

Authors may withdraw a manuscript without giving a reason within 24 hours of submission. After that, a withdrawal request must include a detailed explanation of the reasons, out of respect for the effort already invested by editors and reviewers.

Publication costs and after acceptance

Article processing charge

1695 EUR

Articles are open access and freely available immediately upon publication. The APC covers editorial tools, article production and hosting, indexing and other editorial services. Full APC details

Institutional discounts

  • Institution of the first, last or corresponding author has a signed Agreement: 15% off
  • Institution of the first, last or corresponding author has a signed MoU: 10% off

Institutional Open Access Membership Program · Benefits for reviewers

Language and writing assessment

Accepted manuscripts are evaluated for the quality of English and scientific writing. Manuscripts that need significant improvement are returned to the authors for correction. If the corrections do not meet publication standards, authors are advised to use a professional language editing service.

Graphical abstracts, Highlights, and In brief

All newly published scientific articles in Biomolecules and Biomedicine will include an opening page featuring a Graphical Abstract, Highlights, and an In Brief summary. Graphical abstracts should clearly communicate the article’s key question, main findings, and take-home message. Highlights summarize the principal findings, while In Brief explains the main message and its significance. The editorial office prepares or adapts these materials during production. Author-submitted graphical abstracts may be edited, redesigned, or reformatted to communicate these elements clearly and ensure consistency with the journal’s visual style. All changes must remain faithful to the accepted manuscript. Authors will review the opening page during proofreading and identify any corrections needed to ensure scientific accuracy.

Author summary

Authors of accepted articles write a 200–250 word non-technical summary of their research for non-expert readers, and are asked for a photo of themselves, their research group or their institution. If no photo is provided, a figure from the article or an illustration chosen by the Blog Editor is used.

The summary is published on the journal's blog (blog.biomolbiomed.com) and social media, and sent to web-based medical news services, which improves the visibility of the article and its authors. See the Author summary guidelines.

Video summary

Instead of a text summary, authors may present their findings as a video. The same principles apply. See the Video summary guidelines.

Corrections and retractions

To report an error that warrants correction or retraction, email [email protected] with the article citation and DOI, a description of the error, the proposed correction text and any supporting files. Post-publication notices are assigned DOIs and linked to the affected articles.

  • Author correction (corrigendum): notification by the authors of a significant error affecting the publication record, the scientific integrity of the work, or the reputation of the authors or the journal. For corrections to results, include the underlying raw data. The same applies to authorship corrections, such as a changed name. Corrigenda require a separate APC; see the APC page.
  • Retraction: all co-authors sign a retraction that states the error and briefly explains how the conclusions are affected. Where co-authors disagree, the Editors may seek the advice of independent reviewers and apply the change they consider most appropriate, noting the dissenting authors in the published text.

Policies and contact

Copyright. Articles are published under the Creative Commons Attribution (CC BY) license. Authors retain copyright and allow anyone to download, reuse, reprint, modify, distribute and copy the content, provided the original authors and source are cited.

Editorial policies. Ethics, authorship, competing interests and related policies are described in the Editorial policies.

Editorial Office. [email protected]

Most Cited Paper Award

The award is granted annually to the article published in Biomolecules and Biomedicine that has received the most citations according to Dimensions. It is presented each February for articles published three years earlier; for example, the 2026 award recognizes the most cited article from 2023.

  • Eligibility: all research articles and reviews published in the relevant year, automatically. Editorials, letters and case reports are excluded. No application or nomination is needed.
  • Tie-break: the paper with the higher Relative Citation Ratio.
  • The award includes: a digital certificate; a featured profile and interview on the journal's website and social media; a highlight on the homepage and in the newsletter; an APC waiver for one future publication; a digital badge for LinkedIn, ORCID, ResearchGate and institutional websites; and an official letter to the awardee's institution.

Each year the journal also publishes a list of the top 5 most cited papers.

Ready to submit?

Log in to submit

Privacy Statement